Research Material • WOLVERINE™ 20 mg
WOLVERINE™ 20 mg Research Peptide Blend
WOLVERINE™ is a defined two-component lyophilized research blend
containing BPC-157 and TB-500 in a balanced 20 mg formulation,
supplied by Royal Peptides exclusively for controlled laboratory,
analytical, and scientific research applications.
2-Component Blend
20 mg Total
10 mg + 10 mg
Lyophilized Material
Batch Traceability
Research Use Only
Not for human or veterinary use, administration, ingestion,
injection, compounding, diagnostic, therapeutic, clinical,
or personal use.
01
Blend Profile
WOLVERINE™ Research Material
Royal Peptides WOLVERINE™ is a defined multi-component research
preparation combining BPC-157 and TB-500 within a single
lyophilized vial.
Each vial contains a total of 20 mg of research material:
10 mg BPC-157 and 10 mg TB-500. The equal-component
formulation provides a clearly identified 1:1 quantitative
composition for laboratory research and analytical documentation.
WOLVERINE™ is supplied strictly as a laboratory research material.
References to its individual components or scientific literature
are provided solely for compound identification, analytical
context, and research documentation.
02
Defined Composition
WOLVERINE™ 20 mg Blend Composition
WOLVERINE™ combines two separately identifiable peptide research
materials at equal stated quantities within a single lyophilized
research preparation.
BPC-157
10 mg
Peptide research component
TB-500
10 mg
Peptide research component
Total Research Material Per Vial
20 mg
03
Component Identification
Two-Component Research Formulation
The two components of WOLVERINE™ are independently identifiable
research materials. The descriptions below are provided for
material identification and scientific research context only.
BPC-157 • 10 mg
Synthetic peptide research material incorporated at a defined
10 mg quantity within the WOLVERINE™ formulation.
TB-500 • 10 mg
Peptide research material incorporated at a defined 10 mg
quantity as the second component of the formulation.
Balanced Composition
Each component represents an equal stated quantity within
the formulation, producing a documented 10:10 mg composition.
Defined Research Material
Combining both identified materials in one preparation
provides laboratories with a defined multi-component sample
for appropriately designed research workflows.
04
Research Environment
Controlled Multi-Component Research
WOLVERINE™ is intended for controlled laboratory environments
where defined multi-component peptide materials are required for
analytical, comparative, or experimental research workflows.
Analytical Characterization
Appropriate analytical methods may be used to investigate
material identity, composition, purity, and other measurable
characteristics of the research sample.
Multi-Component Analysis
The formulation provides two identified peptide research
materials within one defined laboratory sample.
Comparative Research
Qualified laboratories may incorporate the material into
appropriately designed comparative or reference-based
experimental systems.
Laboratory Documentation
Defined composition, product identification, lot information,
and applicable analytical records support material traceability.
05
Quality Documentation
Batch-Specific Analytical Information
Research evaluation should rely on documentation associated with
the specific WOLVERINE™ production lot under investigation.
General product-page information should not replace applicable
batch-specific analytical documentation.
- Blend and component identification
- Production lot or batch reference
- Declared component quantities
- Analytical testing information
- Purity information where applicable
- Testing methodology where documented
- Certificate of Analysis information where available
- Research material traceability
06
Traceability
Research Records & Batch Control
Maintaining clear laboratory records helps associate analytical
observations with the specific WOLVERINE™ production lot used
within an experimental workflow.
Material Identification
Record the WOLVERINE™ product identifier, stated BPC-157 and
TB-500 composition, applicable lot reference, date received,
and internal laboratory reference information.
Analytical Records
Preserve applicable analytical documentation, laboratory
observations, experimental results, storage records, and
internal research documentation.
07
Laboratory Protocol
Handling & Storage
Professional Laboratory Handling
WOLVERINE™ should be handled by personnel familiar with
appropriate laboratory procedures, contamination control,
research-material identification, and laboratory safety
practices.
Storage & Records
Follow storage information associated with the applicable
product label and batch documentation. Maintain appropriate
laboratory storage and material-control records.
08
Important Restrictions
Research Use Limitations
Royal Peptides WOLVERINE™ is supplied exclusively as a laboratory
research material. It is not offered or represented as a medicine,
pharmaceutical preparation, dietary supplement, food, cosmetic,
or consumer health product.
- Not for human administration
- Not for veterinary administration
- Not for ingestion or injection
- Not for personal experimentation
- Not for pharmaceutical compounding
- Not for pharmacy preparation
- Not for diagnostic or therapeutic use
- Not for clinical use
09
Research FAQ
WOLVERINE™ Research Questions
What is WOLVERINE™ 20 mg?
WOLVERINE™ is a two-component lyophilized research blend
supplied by Royal Peptides for controlled laboratory,
analytical, and scientific research.
What does WOLVERINE™ contain?
Each vial contains 10 mg BPC-157 and 10 mg TB-500,
providing a total stated research-material content of 20 mg.
What is the component ratio?
WOLVERINE™ contains equal stated quantities of BPC-157 and
TB-500: 10 mg of each component, producing a 1:1 quantitative
formulation.
Is WOLVERINE™ a single peptide?
No. WOLVERINE™ is a multi-component research formulation
containing two identified peptide research materials within
one lyophilized vial.
Is WOLVERINE™ intended for human use?
No. Royal Peptides supplies WOLVERINE™ strictly for laboratory
research. It is not intended for human or veterinary
administration.
Does Royal Peptides provide dosing instructions?
No. Royal Peptides does not provide dosing, administration,
injection, prescribing, treatment, or personal-use instructions
for WOLVERINE™ or its individual research components.
Why is the batch number important?
Batch-specific analytical documentation corresponds to a
particular production lot. Recording the applicable lot
reference supports traceability between the research material,
analytical documentation, and laboratory records.
Is analytical documentation available?
Batch-specific analytical documentation may be available
for the applicable production lot. Researchers should review
documentation corresponding to the specific material received.
Research Use Only
Laboratory Research Material
WOLVERINE™ is supplied for laboratory research use only.
Not for human or veterinary use. Not intended for administration,
ingestion, injection, personal experimentation, pharmaceutical
compounding, pharmacy preparation, diagnostic use, therapeutic
use, or clinical use. Nothing on this page constitutes medical
advice or represents this research material as intended to
diagnose, treat, cure, mitigate, or prevent any disease or
medical condition.